*All other brand or product names located in this site are Trademarks of their respective holders.
Tofacitinib Tablets
New product launched on June 4, 2026.
NDC number :
60505-6263-06
Material number :
70488
Active ingredient :
Tofacitinib Citrate
Bioequivalent to * :
XELJANZ®
Therapeutic class (AHFS) :
Janus Kinase Inhibitors, Misc
Strength :
5MG
Pack size (form) :
60 TABLET (BOTTLE)
Dosage form :
Tablet, Film Coated
Scored :
NO
Color :
White to off-white
Shape :
Round, biconvex film-coated tablet
Markings :
Engraved TC over 5 on one side, plain on the other side
Route of administration :
Oral
Storage condition :
Controlled Room Temperature (68 - 77 degrees F)
Minimum order quantity :
1
Multiple order quantity :
1
Bar code to unit-of-use :
Yes
Latex free :
Yes
Sugar free :
Yes
Dye free :
No
Alcohol free :
Yes
Preservative free :
Yes
Hazardous material :
Yes
Product resources :
photo not available
Packaging information :
| Length | Width | Height | Weight | Units/Pack | |
|---|---|---|---|---|---|
| Unit | 1.9 in | 1.9 in | 2.6 in | 0.048 lb | N/A |
| Inner | 7.4 in | 5.6 in | 2.6 in | 0.574 lb | 12 |
| Case | 11.7 in | 8.1 in | 9.3 in | 3.947 lb | 72 |